Induced Pluripotent Stem Cells Market

Table of Content

Table of Content

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy

3. Induced Pluripotent Stem cells Market Opportunity Analysis
     3.1. Macro-Economic Factors
     3.2. Opportunity Analysis

4. Market Background
     4.1. Parent Market Overview
     4.2. Induced Pluripotent Stem Cell Timeline
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Trends

5. Macroeconomic Assumptions

6. Global Economic Outlook
     6.1. Gross Domestic Product by Region & Country, 2006 – 2021
     6.2. Healthcare Indicators

7. Key Inclusions
     7.1. Usage Trend in Industry
     7.2. Active Researchers in Stem Cell Research
     7.3. Induced Pluripotent Stem Cell Therapy for Cardiovascular Disease
     7.4. In-Vivo Modelling for Neurological Disorder Using Induced Pluripotent Stem Cells
     7.5. Pipeline Assessment

8. North America Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     8.1. Introduction
     8.2. Regional Market Trends
     8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            8.3.1. U.S.
            8.3.2. Canada
     8.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     8.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            8.5.1. Hepatocytes
            8.5.2. Fibroblasts
            8.5.3. Keratinocytes
            8.5.4. Neurons
            8.5.5. Others
     8.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     8.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            8.7.1. Drug Development
            8.7.2. Toxicity testing
            8.7.3. Regenerative Medicine
            8.7.4. Others
     8.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
     8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            8.9.1. Academic & Research Institutes
            8.9.2. Biotechnology companies
            8.9.3. Others
     8.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
     8.11. Drivers and Restraints: Impact Analysis
     8.12. Market Attractiveness Analysis
            8.12.1. By Country
            8.12.2. By Cell Type
            8.12.3. By Application
            8.12.4. By End User
     8.13. Key Market Participants – Intensity Mapping
     8.14. Drivers and Restraints – Impact Analysis

9. Latin America Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     9.1. Introduction
     9.2. Regional Market Trends
     9.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            9.3.1. Argentina
            9.3.2. Brazil
            9.3.3. Mexico
            9.3.4. Rest of Latin America
     9.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     9.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            9.5.1. Hepatocytes
            9.5.2. Fibroblasts
            9.5.3. Keratinocytes
            9.5.4. Neurons
            9.5.5. Others
     9.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     9.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            9.7.1. Drug Development
            9.7.2. Toxicity testing
            9.7.3. Regenerative Medicine
            9.7.4. Others
     9.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
     9.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            9.9.1. Academic & Research Institutes
            9.9.2. Biotechnology companies
            9.9.3. Others
     9.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
     9.11. Drivers and Restraints: Impact Analysis
     9.12. Market Attractiveness Analysis
            9.12.1. By Country
            9.12.2. By Cell Type
            9.12.3. By Application
            9.12.4. By End User
     9.13. Key Market Participants – Intensity Mapping
     9.14. Drivers and Restraints – Impact Analysis
     9.15. Key Mergers & Acquisitions

10. Europe Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     10.1. Introduction
     10.2. Regional Market Trends
     10.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            10.3.1. Germany
            10.3.2. U.K.
            10.3.3. France
            10.3.4. Italy
            10.3.5. Spain
            10.3.6. Russia
            10.3.7. Rest of Europe
     10.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     10.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            10.5.1. Hepatocytes
            10.5.2. Fibroblasts
            10.5.3. Keratinocytes
            10.5.4. Neurons
            10.5.5. Others
     10.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     10.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            10.7.1. Drug Development
            10.7.2. Toxicity testing
            10.7.3. Regenerative Medicine
            10.7.4. Others
     10.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
     10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            10.9.1. Academic & Research Institutes
            10.9.2. Biotechnology companies
            10.9.3. Others
     10.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
     10.11. Drivers and Restraints: Impact Analysis
     10.12.Market Attractiveness Analysis
            10.12.1. By Country
            10.12.2. By Cell Type
            10.12.3. By Application
            10.12.4. By End User
     10.13. Key Market Participants – Intensity Mapping
     10.14. Drivers and Restraints – Impact Analysis
     10.15. Key Mergers & Acquisitions

11. Asia Pacific Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     11.1. Introduction
     11.2. Regional Market Trends
     11.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            11.3.1. Japan
            11.3.2. India
            11.3.3. Australia and New Zealand
            11.3.4. Rest of Asia Pacific
     11.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     11.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            11.5.1. Hepatocytes
            11.5.2. Fibroblasts
            11.5.3. Keratinocytes
            11.5.4. Neurons
            11.5.5. Others
     11.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     11.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            11.7.1. Drug Development
            11.7.2. Toxicity testing
            11.7.3. Regenerative Medicine
            11.7.4. Others
     11.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
     11.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            11.9.1. Academic & Research Institutes
            11.9.2. Biotechnology companies
            11.9.3. Others
     11.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
     11.11. Drivers and Restraints: Impact Analysis
     11.12. Market Attractiveness Analysis
            11.12.1. By Country
            11.12.2. By Cell Type
            11.12.3. By Application
            11.12.4. By End User
     11.13. Key Market Participants – Intensity Mapping
     11.14. Drivers and Restraints – Impact Analysis
     11.15. Key Mergers & Acquisitions

12. China Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     12.1. Introduction
     12.2. Key Regulations
     12.3. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            12.3.1. Hepatocytes
            12.3.2. Fibroblasts
            12.3.3. Keratinocytes
            12.3.4. Neurons
            12.3.5. Others
     12.4. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     12.5. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            12.5.1. Drug Development
            12.5.2. Toxicity testing
            12.5.3. Regenerative Medicine
            12.5.4. Others
     12.6. Market Size (US$ Mn) Forecast By Application, 2018–2026
     12.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            12.7.1. Academic & Research Institutes
            12.7.2. Biotechnology companies
            12.7.3. Others
     12.8. Market Size (US$ Mn) Forecast By End User, 2018–2026
     12.9. Drivers and Restraints: Impact Analysis
     12.10. Market Attractiveness Analysis
            12.10.1. By Cell Type
            12.10.2. By Application
            12.10.3. By End User
     12.11. Key Market Participants – Intensity Mapping
     12.12. Drivers and Restraints – Impact Analysis
     12.13. Key Mergers & Acquisitions

13. Middle East & Africa Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     13.1. Introduction
     13.2. Key Regulations
     13.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            13.3.1. GCC Countries
            13.3.2. South Africa
            13.3.3. Rest of MEA
     13.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     13.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            13.5.1. Hepatocytes
            13.5.2. Fibroblasts
            13.5.3. Keratinocytes
            13.5.4. Neurons
            13.5.5. Others
     13.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     13.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            13.7.1. Drug Development
            13.7.2. Toxicity testing
            13.7.3. Regenerative Medicine
            13.7.4. Others
     13.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
     13.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            13.9.1. Academic & Research Institutes
            13.9.2. Biotechnology companies
            13.9.3. Others
     13.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
     13.11. Drivers and Restraints: Impact Analysis
     13.12. Market Attractiveness Analysis
            13.12.1. By Country
            13.12.2. By Cell Type
            13.12.3. By Application
            13.12.4. By End User
     13.13. Key Market Participants – Intensity Mapping
     13.14. Drivers and Restraints – Impact Analysis
     13.15. Key Mergers & Acquisitions

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Market Structure Analysis
     16.1. Market Structure by Tier of Companies
     16.2. Market Share Analysis (2016) for Top Players, By Region

17. Competition Analysis
     17.1. Competition Dashboard
     17.2. Competition Benchmarking
     17.3. Company Deep Dive
            17.3.1. Thermo Fisher Scientific Inc.
                     17.3.1.1. Overview
                     17.3.1.2. Product and Application Portfolio
                     17.3.1.3. Production Footprint
                     17.3.1.4. Sales Footprint
                     17.3.1.5. Channel Footprint
                     17.3.1.6. Strategy
                                17.3.1.6.1. Marketing Strategy
                                17.3.1.6.2. Product Strategy
                                17.3.1.6.3. Channel Strategy
            17.3.2. FUJIFILM Holdings Corporation (Cellular Dynamics)
                     17.3.2.1. Overview
                     17.3.2.2. Product and Application Portfolio
                     17.3.2.3. Production Footprint
                     17.3.2.4. Sales Footprint
                     17.3.2.5. Channel Footprint
                     17.3.2.6. Strategy
                                17.3.2.6.1. Marketing Strategy
                                17.3.2.6.2. Product Strategy
                                17.3.2.6.3. Channel Strategy
            17.3.3. Horizon Discovery Group plc.
                     17.3.3.1. Overview
                     17.3.3.2. Product and Application Portfolio
                     17.3.3.3. Production Footprint
                     17.3.3.4. Sales Footprint
                     17.3.3.5. Channel Footprint
                     17.3.3.6. Strategy
                                17.3.3.6.1. Marketing Strategy
                                17.3.3.6.2. Product Strategy
                                17.3.3.6.3. Channel Strategy
            17.3.4. Takara Bio Inc.
                     17.3.4.1. Overview
                     17.3.4.2. Product and Application Portfolio
                     17.3.4.3. Production Footprint
                     17.3.4.4. Sales Footprint
                     17.3.4.5. Channel Footprint
                     17.3.4.6. Strategy
                                17.3.4.6.1. Marketing Strategy
                                17.3.4.6.2. Product Strategy
                                17.3.4.6.3. Channel Strategy
            17.3.5. Cell Applications, Inc.
                     17.3.5.1. Overview
                     17.3.5.2. Product and Application Portfolio
                     17.3.5.3. Production Footprint
                     17.3.5.4. Sales Footprint
                     17.3.5.5. Channel Footprint
                     17.3.5.6. Strategy
                                17.3.5.6.1. Marketing Strategy
                                17.3.5.6.2. Product Strategy
                                17.3.5.6.3. Channel Strategy
            17.3.6. Lonza Group Ltd.
                     17.3.6.1. Overview
                     17.3.6.2. Product and Application Portfolio
                     17.3.6.3. Production Footprint
                     17.3.6.4. Sales Footprint
                     17.3.6.5. Channel Footprint
                     17.3.6.6. Strategy
                                17.3.6.6.1. Marketing Strategy
                                17.3.6.6.2. Product Strategy
                                17.3.6.6.3. Channel Strategy

18. Global Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026, By Region
     18.1. Introduction/Key Findings
     18.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017
     18.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
            18.3.1. North America
            18.3.2. Latin America
            18.3.3. Europe
            18.3.4. Asia Pacific
            18.3.5. Middle East & Africa
            18.3.6. China
     18.4. Market Attractiveness Analysis By Region

19. Global Induced Pluripotent Stem Cells Analysis 2013–2017 and Forecast 2018–2026, By Cell Type
     19.1. Introduction/Key Findings
     19.2. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            19.2.1. Hepatocytes
            19.2.2. Fibroblasts
            19.2.3. Keratinocytes
            19.2.4. Neurons
            19.2.5. Others
     19.3. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     19.4. Market Attractiveness Analysis By Cell Type

20. Global Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026, By Application
     20.1. Introduction/Key Findings
     20.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            20.2.1. Drug Development
            20.2.2. Toxicity testing
            20.2.3. Regenerative Medicine
            20.2.4. Others
     20.3. Market Size (US$ Mn) Forecast By Application, 2018–2026
     20.4. Market Attractiveness Analysis By Application

21. Global Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026, By End User
     21.1. Introduction/Key Findings
     21.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            21.2.1. Academic & Research Institutes
            21.2.2. Biotechnology companies
            21.2.3. Others
     21.3. Market Size (US$ Mn) Forecast By End User, 2018–2026
     21.4. Market Attractiveness Analysis By End User

22. Global Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     22.1. Market Value Share Analysis By All Segment
     22.2. Y-o-Y Growth Analysis By All Segment
     22.3. Absolute $ Opportunity

23. Assumptions and Acronyms

24. Research Methodology

List of Tables

List of Tables

Table 01: Comparison of Stem Cell Types
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 04: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials 
Table 05: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 06: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 07: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 08: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 09: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 10: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials
Table 11: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 12: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 13: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 14: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 15: North America Induced Pluripotent Stem Cell Market Company Intensity Map
Table 16: Economic support and stem cell research for the major  countries in Latin America, (2013)
Table 17: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 18: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 19: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 20: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 21: Latin America Induced Pluripotent Stem Cell Market Company Intensity Map
Table 22: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 23: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 24: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 25: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 26: Europe Induced Pluripotent Stem Cell Market Company Intensity Map
Table 28: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 29: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 30: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 31: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 32: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Company Intensity Map
Table 33: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 34: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 35: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 36: China Induced Pluripotent Stem Cell Market Company Intensity Map
Table 37: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 38: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 39: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 40: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 41: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Company Intensity Map
Table 42: Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Region
Table 43: Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type
Table 44: Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type
Table 45: Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User

List of Chart

List of Figures

Figure 01: All R&D expenditure, by Source of Fund, 2011 
Figure 02: R&D expenditure in Life Science, by R&D Field, 2011 
Figure 03: Leading cause of Death, 2014
Figure 04: Global Stem Cell Market Overview (2016E)
Figure 05: Main Obstacles in Stem Cell Research  
Figure 06: Number of Companies (estimated) Offering iPSC Research products, by Year 
Figure 07: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 08: The Number of Estimated Active Researchers in Stem Cell Research Worldwide 
Figure 09: North America Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
Figure 10: North America Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
Figure 11: iPSC Specific U.S. Patents, by patent type, 2015
Figure 12: National contribution to iPSC invention, by country, 2014 
Figure 13: Total number of patents for iPSC technologies (Est.)   
Figure 14: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
Figure 15: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 16: North America Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 17: U.S. Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 18: U.S. Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 19: Canada Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 20: Canada Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 21: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes
Figure 22: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes
Figure 23: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts
Figure 24: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts
Figure 25: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes
Figure 26: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes
Figure 27: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons
Figure 28: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons
Figure 29: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others
Figure 30: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others
Figure 31: North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type 
Figure 32: North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 33: North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 34: North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
Figure 35: Latin America Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
Figure 36: Latin America Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
Figure 37: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
Figure 38: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 39: Latin America Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 40: Brazil Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 41: Brazil Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 42: Mexico Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 43: Mexico Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 44: Argentina Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 45: Argentina Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 46: Rest of Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 47: Rest of Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 48: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes
Figure 49: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes
Figure 50: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts
Figure 51: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts
Figure 52: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes
Figure 53: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes
Figure 54: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons
Figure 55: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons
Figure 56: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others
Figure 57: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others
Figure 58: Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type 
Figure 59: Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 60: Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 61: Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
Figure 62: Europe Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
Figure 63: Europe Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
Figure 64: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
Figure 65: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 66: Europe Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 67: Germany Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 68: Germany Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 69: U.K. Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 70: U.K. Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 71: France Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 72: France Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 73: Italy Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 74: Italy Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 75: Spain Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 76: Spain Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 77: Russia Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 78: Russia Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 79: Rest of Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country
Figure 80: Rest of Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 81: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes
Figure 82: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes
Figure 83: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts
Figure 84: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts
Figure 85: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes
Figure 86: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes
Figure 87: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons
Figure 88: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons
Figure 89: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others
Figure 90: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others
Figure 91: Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type 
Figure 92: Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 93: Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 94: Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
Figure 95: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
Figure 96: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
Figure 97: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
Figure 98: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 99: APEC Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 100: Japan Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 101: Japan Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 102: India Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 103: India Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 104: Australia and New Zealand Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 105: Australia and New Zealand Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 106: Rest of APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 107: Rest of APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 108: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes
Figure 109: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes
Figure 110: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts
Figure 111: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts
Figure 112: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes
Figure 113: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes
Figure 114: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons
Figure 115: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons
Figure 116: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others
Figure 117: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others
Figure 118: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type 
Figure 119: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 120: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 121: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
Figure 123: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
Figure 124: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 125: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes
Figure 126: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes
Figure 127: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts
Figure 128: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts
Figure 129: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes
Figure 130: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes
Figure 131: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons
Figure 132: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons
Figure 133: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others
Figure 134: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others
Figure 135: China Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type 
Figure 136: China Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 137: China Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 138: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Value Share (2017A), By Country
Figure 139: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User
Figure 140: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017
Figure 141: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 142: MEA Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 143: GCC Countries Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 144: GCC Countries Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 145: South Africa Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 146: South Africa Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 147: Rest of MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017
Figure 148: Rest of MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 149: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes
Figure 150: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes
Figure 151: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts
Figure 152: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts
Figure 153: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes
Figure 154: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes
Figure 155: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons
Figure 156: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons
Figure 157: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others
Figure 158: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others
Figure 159: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type 
Figure 160: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 161: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 162: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country
Figure 163: Revenue Contribution by Tier Type (2016)
Figure 164: Global Induced Pluripotent Stem Cell Market Share (%) Analysis
Figure 165: Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Region
Figure 166: Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type
Figure 167: Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type
Figure 168: Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User
Figure 169: Global Induced Pluripotent Stem Cell Market Size and Y-o-Y, 2013 - 2017
Figure 170: Global Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 171: Global Induced Pluripotent Stem Cell Market Absolute $ Opportunity, 2017–2026

Description

Overview of the iPS Cell Market with Reference to the Global Healthcare Sector Outlook

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare

• Current expenditure on health, % of gross domestic product
• Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
• Annual growth rate of current expenditure on health, per capita, in real terms
• Out-of-pocket expenditure, % of current expenditure on health
• Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
• Physicians, Density per 1000 population (head counts)
• Nurses, Density per 1000 population (head counts)
• Total hospital beds, per 1000 population
• Curative (acute) care beds, per 1000 population
• Medical technology, Magnetic Resonance Imaging units, total, per million population
• Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

PMR utilizes a triangulation methodology that is primarily based on overall expenditure on life science research and R&D funding and capital equipment installed base to obtain precise market estimations and insights on life science and biotechnology associated products, technologies, applications and services. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country-specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product and service offerings, equipment installed base in end use facilities, adoption rate and future impact of new technologies. Additionally, per capita consumption of kits, reagents and consumables among end users is tracked at a granular level to obtain the most accurate information. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side respondents such as laboratory managers, procurement managers, research supervisors at academic and research institutes, as well as key opinion leaders in addition to supply-side respondents such as equipment and reagent manufacturers, custom solution and service providers who provide valuable insights on trends, research application of products and technologies, purchasing patterns, services offered and associated pricing.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project year-on-year growth rates. These Y-o-Y growth projections are checked and aligned as per associated industry/product lifecycles and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse annual reports_bk_01_01_2020 of various companies, investor presentations, SEC filings, 10k reports_bk_01_01_2020 and earning call transcripts operating in the market to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at tier-level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as overall life science research expenditure, R&D funding, industry based demand driving factors impacting the market and its forecast trends apart from other macroeconomic factors.

Standard Report Structure

• Executive Summary
• Market Definition
• Macro-economic analysis
• Parent Market Analysis
• Market Overview
• Forecast Factors
• Segmental Analysis and Forecast
• Regional Analysis
• Competition Analysis